Placental Vascular Reactivity Can Help ID Fetal Congenital Heart Disease
via HealthDayFRIDAY, Feb. 27, 2026 -- Placental vascular reactivity (PLVR) can help identify fetal congenital heart disease (CHD), according to a study recently published in Magnetic Resonance in Medicine.
Vidya Rajagopalan, Ph.D., from the Keck School of Medicine at the University of Southern California in Los Angeles, and colleagues conducted a prospective cohort study to compare PLVR, the fetally mediated placental response to transient changes in maternal carbon dioxide (CO2) quantified using blood oxygen level-dependent (BOLD) magnetic resonance imaging (MRI), in pregnancies with and without fetal CHD. As pregnant women followed audio-visual breathing cues, placental BOLD MRI was acquired concurrently with maternal end-tidal CO2 (EtCO2) for seven to eight minutes. A coherence-weighted general linear model was used to compute PLVR between MRI signal and EtCO2 stimulus. Global PLVR was the mean of voxel-wise PLVR across the placenta.
A total of 103 pregnant women were included in the study: 31 with fetal CHD and 72 with healthy fetuses. The researchers found that compared with the non-CHD group, PLVR was lower in CHD (0.024 ± 0.02 versus 0.03 ± 0.04 ΔBOLD/mmHg CO2). In CHD versus non-CHD groups, maternal diabetes had differential effects on PLVR.
"Measuring placental function in real time gives us a window into how these babies are developing," Rajagopalan said a statement. "That's especially important in congenital heart disease, where the placenta may play a key role in supporting brain development."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-28 01:36
Read more
- Postadenotonsillectomy Respiratory Volume Monitoring Feasible in Obstructive Sleep Apnea
- Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission
- Lindsey Vonn Says Olympic Crash Nearly Cost Her a Leg
- PTC Therapeutics Provides Regulatory Update on Translarna
- Metabolic Dysfunction Is Main Driver of Chronic Kidney Disease Risk
- Risk Factors Associated With Child Food Allergy Identified
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions